Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NVA237
NVA237
Novartis' duo of COPD drugs clears Phase III on the path to an FDA decision
Fierce Biotech
Fri, 05/22/15 - 10:41 am
Novartis
COPD
FDA
NVA237
QVA149
Novartis Seeks U.S. Approval for Two COPD Drugs
Bloomberg
Thu, 01/8/15 - 08:00 am
Novartis
COPD
QVA149
NVA237
Novartis Drug for Smoker’s Cough Boosts Lung Function in Study
Bloomberg
Wed, 05/2/12 - 09:20 am
Novartis
smoker's cough
NVA237
Novartis' Respiratory Ambitions Are On Track
Seeking Alpha
Wed, 09/28/11 - 09:16 am
Novartis
NVA237
COPD
Novartis Says Drug Improves COPD Symptoms
FOX Business
Tue, 09/27/11 - 11:19 am
COPD
Novartis
NVA237